Huntington’s Disease Program
Patients also have the opportunity to participate in research, to both advance the understanding of HD through observational trials and help test new potential therapies. Boston University is a research site of the Huntington Study Group. Currently, studies are ongoing for people who are at risk for developing HD as well as observational and investigational drug trials.
Dr Samuel Frank is an Associate Professor of Neurology at Boston University, specializing in the treatment of movement disorders, including HD. He is the inpatient neurology consultant for the Specialized Huntington’s Disease Unit at Tewksbury State Hospital and has active HD clinics at Boston University and the Boston Veterans Administration Hospital. He is the site Principal Investigator for 2CARE, and the recently completed COHORT and PHAROS studies. He played a key role in the recent studies used to obtain FDA approval for tetrabenazine use for chorea. Dr. Frank is also an active member of the New England HDSA Family services committee and the National HDSA Education Committee.
For additional information or to schedule an appointment please contact Allyson Gormley, LICSW at (617) 638-7747.